$AMC Entertainment (AMC.US)$
It is just starting... 🤫

Currently, Wood and her disruptive vision are facing a huge test. The flagship fund ARK Innovation ETF (ARKK) just had its worst weekly performance since February, falling 12.7% to the lowest level in over a year. Six out of the company's eight strategies recorded declines in 2021, with the worst performing strategy having a decline of 37%. $ARK Genomic Revolution ETF (ARKG.US)$ ARKK opened in the New York market with an initial drop of 4.8% and recovered by the closing, rising 1.5%. The fund has fallen nearly 24% this year.
ARK's actively managed ETFs made a total of 7 transactions on the day, buying 5 stocks and selling 2 stocks.
② $ARK Fintech Innovation ETF (ARKF.US)$ csi commodity equity index $ARK Innovation ETF (ARKK.US)$ Adding to their position $Signify Health (SGFY.US)$ is a leading healthcare platform that utilizes advanced analytics, technology, and a nationwide network of healthcare providers to create and support value-based payment programs.
ARKK position increased $Teladoc Health (TDOC.US)$ Teladoc is a telehealth company that provides on-demand healthcare through mobile devices, the internet, video, and phone. Its solutions connect physicians, healthcare professionals, healthcare providers, and users directly, offering a wide range of acute diagnoses such as upper respiratory infections, urinary tract infections, sinusitis, skin conditions, anxiety, smoking cessation, and more.
Sell ARKK. $Editas Medicine (EDIT.US)$Editas Medicine is a genome editing company. The company treats genetic diseases by correcting pathogenic genes.
Medicine是一家基因组编辑公司。该公司通过修正致病基因治疗遗传疾病。

Hello Mooers, Long time no see!
Congratulations to @Madiq Izichi and @Spritz the first and last mooers to answer the Enter to Win: Stock by chart challenge S11 correctly! The correct answer are $Sony (SONY.US)$ $Unilever (UL.US)$ $Meta Platforms (FB.US)$
Congratulations to @HopeAlways @Syuee @KT88 commenting insightful information on the correct stock!
The reward has been issued, thanks again for joining the game!
Tips: Join this exciting game on every Friday, If you want to win rewards which you can...

$Ocugen (OCGN.US)$
1. U.S. Phase 3 Bridging Study:
OCGN submitted an IND application to FDA on October 27, 2021, and FDA issued a Clinical Hold to OCGN on November 26, 2021. Currently, WE are waiting for the response from OCGN to FDA. The OCGN will receive a full response from the FDA on or after December 26, 2021. FDA will proceed with approval within 30 days of receiving OCGN's response.

In trading on Friday, shares of $AMC Entertainment (AMC.US)$  and   $GameStop (GME.US)$ crossed below their 200-day moving average.
AMC shares were trading lower last week after the CDC confirmed the first Omicron case in the US. Theaters shut down in 2020 amid the start of the pandemic and variant uncertainty has driven fears of possible lockdown measures.
AMC closed Friday’s session lower by 4.2% at $29.01, well off the stock's intraday low of $25.31.
Shares of GameStop, were trading lower as well, following worse-than-expected US job growth data.
GameStop closed Friday’s session lower by 5.1% at $172.39, off the intraday low of $159.05.
If you had $1,000 right now, would you buy the dip in AMC or GME?